The Ensign Group, Inc. (NASDAQ:ENSG) insider Spencer Burton sold 1,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $60.00, for a total transaction of $60,000.00. Following the sale, the insider now owns 19,351 shares of the company’s stock, valued at approximately $1,161,060. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
The Ensign Group stock traded up $0.03 during trading hours on Wednesday, reaching $60.26. 370,554 shares of the stock were exchanged, compared to its average volume of 297,373. The stock has a market capitalization of $3.21 billion, a PE ratio of 33.66, a P/E/G ratio of 1.88 and a beta of 0.84. The company has a debt-to-equity ratio of 1.87, a quick ratio of 1.15 and a current ratio of 1.15. The Ensign Group, Inc. has a 52-week low of $34.69 and a 52-week high of $63.00. The company’s 50 day moving average price is $57.44.
The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.51 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.01. The company had revenue of $549.21 million during the quarter, compared to the consensus estimate of $545.09 million. The Ensign Group had a net margin of 4.59% and a return on equity of 17.23%. The Ensign Group’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.45 EPS. Equities research analysts anticipate that The Ensign Group, Inc. will post 2.11 earnings per share for the current fiscal year.
A number of equities analysts have commented on ENSG shares. BidaskClub upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Friday, July 19th. Oppenheimer upped their price objective on shares of The Ensign Group from $52.00 to $58.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th. ValuEngine downgraded shares of The Ensign Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, April 3rd. Finally, Zacks Investment Research downgraded shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 9th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $44.17.
A number of institutional investors have recently made changes to their positions in the business. Norges Bank purchased a new position in shares of The Ensign Group in the 4th quarter valued at about $26,625,000. JPMorgan Chase & Co. increased its holdings in shares of The Ensign Group by 122.9% in the 1st quarter. JPMorgan Chase & Co. now owns 386,823 shares of the company’s stock valued at $19,801,000 after purchasing an additional 213,256 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of The Ensign Group by 64.8% in the 4th quarter. American Century Companies Inc. now owns 430,707 shares of the company’s stock valued at $16,707,000 after purchasing an additional 169,338 shares in the last quarter. Copeland Capital Management LLC increased its holdings in shares of The Ensign Group by 21.2% in the 2nd quarter. Copeland Capital Management LLC now owns 815,400 shares of the company’s stock valued at $46,413,000 after purchasing an additional 142,478 shares in the last quarter. Finally, Millennium Management LLC increased its holdings in shares of The Ensign Group by 761.5% in the 4th quarter. Millennium Management LLC now owns 131,876 shares of the company’s stock valued at $5,115,000 after purchasing an additional 116,569 shares in the last quarter. Institutional investors own 80.91% of the company’s stock.
About The Ensign Group
The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, such as daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.
Further Reading: Dividend Stocks – Are They Right For You?
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.